Who

Ken Buck
Representative, CO-04
RepublicanColoradoCongressformer
Represented CO-4 (Republican), 2015–2024, 5 terms.
In numbers
- Trades disclosed
- 79
- Buys
- 41
- Sells
- 38
- Bought
- $132K–$805K
- Sold
- $38K–$570K
- Companies
- 39
- First trade
- 1 Dec 2016
- Last trade
- 9 Sep 2021
- Last filed
- 17 Oct 2021
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2021filed 17 Oct 2021 | HP Helmerich & PayneOilfield services | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 4 Dec 2017filed 14 Jan 2018 | an asset our copy of the filing does not name | House: U.S. House Clerk Bought | $50K–$100K | filing |
| 4 Dec 2017filed 14 Jan 2018 | Edgewood growth Fund-Retail | House: U.S. House Clerk Bought | $15K–$50K | filing |
| 7 Nov 2017filed 11 Dec 2017 | ABT Abbott LaboratoriesBiotechnology | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | Credit Suisse group Ordinary Shares | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | DBD Diebold NixdorfHardware, Devices & Storage | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | ETN Eaton CorporationMachinery | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | Enel Societa Per Azioni unsponsoredAdR | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | Endonovo Therapeutics | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | ERSTE GROUP BANK AG SPON ADR Trade | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | GSK GskPharmaceuticals | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | HPQ HpHardware, Devices & Storage | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | ING ING GroupMoney-centre banks | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | INTC IntelSemiconductors | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | ABBV AbbViePharmaceuticals | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | IBM International Business MachinesIT Services & Consulting | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | Intesa Sanpaolo Sponsored ADR | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | JNJ Johnson & JohnsonPharmaceuticals | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | JPM JP Morgan Chase & CoMoney-centre banks | House: U.S. House Clerk Sold | $1,001–$15K | filing |
| 7 Nov 2017filed 11 Dec 2017 | PHG Koninklijke Philips N.V. NY RegistryMedical Devices | House: U.S. House Clerk Sold | $1,001–$15K | filing |
News
3% of Colorado ballots returned so far; Former Republican Congressman Ken Buck endorses Democrat Phil Weiser in governor's race; Dark money groups influencing Colorado midterms – KGNU Community Radiokgnu.org · 15 Oct 2026Republican Ken Buck endorses Phil Weiser in Colorado governor's racegazette.com · 14 Oct 2026Bank of America fined US$1.21bil as US flags suspected Chinese money launderingBAC · thestar.com.my · 22 Oct 2026Bank of America Data Put U.S. Child Care at 8% of Household PayBAC · econotimes.com · 22 Oct 2026AbbVie (NYSE:ABBV) & TScan Therapeutics (NASDAQ:TCRX) Financial ComparisonABBV · tickerreport.com · 22 Oct 2026Abbott Laboratories announces a baby formula spinoff companyABT · marketplace.org · 21 Oct 2026Bank of America Names Jim Fitterling and Bill Thomas to Board of DirectorsBAC · prnewswire.com · 21 Oct 2026Abbott anticipates nutrition separation by end of next year and forecasts Q4 adjusted EPS of $1.62-$1.67 (NYSE:ABT)ABT · seekingalpha.com · 21 Oct 2026
2 headlines in the last 90 days name Ken Buck; 10 articles from the last 14 days about the 6 companies they traded most, at most three about any one of them.